AMICUS THERAPEUTICS, INC. — Director's Dealing 2012

Feb 23, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2011-02-03

Reporting Person: Quimi Daphne (Corporate Controller)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$16.57	2017-09-04	Common Stock (10000)		Direct
Stock Options (right to buy)	$10.21	2018-02-05	Common Stock (7000)		Direct
Stock Options (right to buy)	$10.36	2019-02-03	Common Stock (8000)		Direct
Stock Options (right to buy)	$4.16	2019-11-16	Common Stock (15000)		Direct
Stock Optons (right to buy)	$2.81	2020-06-15	Common Stock (6000)		Direct
Stock Options (right to buy)	$5.96	2021-01-19	Common Stock (8750)		Direct
Stock Options (right to buy)	$6.06	2021-06-16	Common Stock (15000)		Direct
Stock Options (right to buy)	$6.45	2022-02-15	Common Stock (8750)		Direct

Footnotes

F1: These options vested and became exercisable in a series of installments. The first installment, which consisted of 25% of the total aggregate number of options granted, vested on September 4, 2008. The remaining options vested and became exercisable in a series of thirty-five equal monthly installments, beginning on October 1, 2008, with a final installment vesting on September 4, 2011.

F2: These options vested and became exercisable in a series of installments. The first installment, which consisted of 25% of the total aggregate number of options granted, vested on February 5, 2009. The remaining options vested and became exercisable in a series of thirty-five equal monthly installments, beginning on March 1, 2009, with a final installment vesting on February 5, 2012.

F3: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on February 3, 2010. The remaining options vest and become exercisable in a series of thirty-five equal monthly installments, beginning on March 1, 2010, with a final installment vesting on February 3, 2013.

F4: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on November 16, 2010. The remaining options vest and become exercisable in a series of thirty-five equal monthly installments, beginning on December 1, 2010, with a final installment vesting on November 16, 2013.

F5: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on June 15, 2011. The remaining options vest and become exercisable in a series of thirty-five equal monthly installments, beginning on July 1, 2011, with a final installment vesting on June 15, 2014.

F6: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on January 19, 2012. The remaining options vest and become exercisable in a series of thirty-five equal monthly installments, beginning on February 1, 2013, with a final installment vesting on January 19, 2015.

F7: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 16, 2012. The remaining options vest and become exercisable in a series of thirty-five equal monthly installments, beginning on July 1, 2012, with a final installment vesting on June 16, 2015.

F8: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on February 15, 2013. The remaining options vest and become exercisable in a series of thirty-five equal monthly installments, beginning on March 1, 2013, with a final installment vesting on February 15, 2016.